Breaking News

Clinverse, eClinical Insights Enter Strategic Partnership

May 23, 2014

To combine ClinPay with clinical technology platform

Clinverse, Inc. and eClinical Insights have formed a strategic partnership around Clinverse's ClinPay solution, which automates sponsor payments to clinical vendors, investigators, and other parties for a clinical trial, and eClinical Insights’ technology platform that provides real time visibility and control across disparate systems and diverse teams, providing actionable information and workflow capabilities.
 
Using the ClinPay application programing interface with eClinical Insights integration framework, aims to offer seamless data integration allowing sponsors to improve the performance of their clinical trials and reduce labor costs associated with payment and accounting processes for clinical vendors and investigative sites.
 
"Together, we are able to offer CROs and clinical trial sponsors a best-of-breed, fully integrated solution that delivers real-time visibility across the eClinical ecosystem," said Denis Connaghan, chief executive officer of Clinverse. "Joint customers stand to gain a measureable return on investment, increased competitive advantage, and decreased ramp-up time and learning curve."
 
"Adding Clinverse as a strategic partner in our integrated technology network enables us to expand the reach and capabilities of our platform," said Peg Regan, president and chief executive officer of eClinical Insights. "This partnership and integrated solution fit seamlessly with our philosophy and approach to improving trial performance across a complex eClinical ecosystem."
  • CROs and Today’s  R&D Landscape

    CROs and Today’s R&D Landscape

    Kristin Brooks, Associate Editor, Contract Pharma||November 9, 2016
    John Lewis of ACRO discusses opportunities, challenges, and the future CRO

  • Choosing Oral Formulations for First-in-man Clinical Trials

    Choosing Oral Formulations for First-in-man Clinical Trials

    Jon Sutch, Senior Manager of Formulation Development, Patheon||October 11, 2016
    Early formulations should be simple, but selecting a simple formulation isn’t as easy as it seems

  • Robust Assay Designs

    Robust Assay Designs

    Tim Wright, Editor, Contract Pharma||October 11, 2016
    Easing the transition from preclinical to clinical research